NFGH
TNGX icon

Nan Fung Group Holdings’s Tango Therapeutics TNGX Stock Holding History

Nan Fung Group Holdings’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-25,500
Closed -$279K – 56
2021
Q4 		$279K Buy
+25,500
New +$307K 0.08% 40

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Boxer Capital
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Casdin Capital
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Cormorant Asset Management
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Southpoint Capital Advisors
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Nan Fung Group Holdings's TNGX Position: Q1 2022 in Review

Nan Fung Group Holdings sold out of Tango Therapeutics (TNGX) in Q1 2022, closing a stake of 25,500 shares — an estimated $279K sold.

Nan Fung Group Holdings first reported a position in TNGX in Q4 2021 and held it in 1 quarter. The position peaked at $279K in Q4 2021. 72 funds tracked by Wall St. Rank hold TNGX as of Q1 2022.

  • Nan Fung Group Holdings reported no remaining Tango Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Nan Fung Group Holdings sold 25,500 Tango Therapeutics shares in Q1 2022, an estimated $279K.
  • Nan Fung Group Holdings first reported a position in Tango Therapeutics in Q4 2021 and held it in 1 quarter.
  • Nan Fung Group Holdings's Tango Therapeutics position peaked at $279K in Q4 2021.
  • 72 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2022.

Based on Nan Fung Group Holdings's 13F filing for Q1 2022, filed 13 May 2022.